Independent ID Practice Economics Calculator
The whole practice in one model: office, hospital, APP and infusion revenue against staffing, drug and overhead cost.
Illustrative assumptions. Default values here are example inputs for demonstration only — not validated reimbursement rates, costs or benchmarks. Replace every field with your own practice’s figures.
Monthly contribution
$13,180
$158,160 annualised · $4,393 per physician per month before partner distribution.
Revenue by stream
- Total monthly revenue
- $140,180
- Provider cost3 physicians + 1 APPs
- $77,000
- Staff and overhead
- $50,000
- Monthly contribution
- $13,180
- Annualised
- $158,160
- Clinical share of revenueConsultation and clinic
- 53%
- Contracted + ancillary shareThe streams a wRVU model cannot see
- 47%
- Break-even consult volumeYou are running 48 per week
- 31 / wk
Contracted services and infusion carry a substantial share of revenue. That is the structure most independent ID practices need — and it means payer and drug policy risk deserves its own line in your risk register.
This is a contribution model, not a P&L. It excludes tax, partner distribution, working capital tied up in drug inventory, and the timing gap between administering therapy and being paid for it.
How this is calculated
- Revenue is built from four independent streams: hospital consultation, outpatient clinic (physician and APP), contracted institutional services, and infusion contribution.
- Weekly volumes are annualised at 4.33 weeks per month.
- Cost is provider compensation (physicians and APPs at their own rates) plus support staff and overhead.
- Break-even consult volume solves for the consults needed to cover whatever the other three streams do not.
What it does not do
- It is a contribution model, not a P&L: no tax, no partner distribution, no depreciation.
- It ignores working capital — in buy-and-bill you pay for drug inventory well before you are paid for it, and that timing gap is real.
- It assumes infusion contribution per unit is already net of drug and nursing cost. Model that separately first.
Now that you have a number
Want to pressure-test this against your actual claims data?
This model is only as good as the assumptions you put into it. Persistex works with independent infectious disease practices on billing, coding and revenue cycle, and a practice review starts from your actual payment and denial data.
Prototype: these routes to a demonstration form. No data is transmitted or stored.
Other tools
Can Independent ID Work? Scenario Model
Test the levers side by side — adding an APP, opening infusion, changing hospital volume, shifting payer mix, adding a provider.
CalculatorInfusion & OPAT Economics Calculator
Drug acquisition, nursing, chair time, supplies and reimbursement across a full course of therapy — by site of care.
DirectoryPayer & Drug Authorization Lookup
A curated route to the authoritative sources: ASP pricing files, HCPCS/J-code updates, coverage determinations, home infusion policy and appeals.
AssessmentPractice Health Check
Score eight signals across revenue cycle, payer mix, referral concentration, authorization performance and infusion economics.